Compounds That Target EPHA8

EPH receptor A8 · 23 compounds in BiohacksAI corpus

EPHA8 (EPH receptor A8) is a biological target with 23 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into EPHA8 modulation for therapeutic and biohacking applications.

View EPHA8 target page →UniProt: P29322 ↗

Most Studied Compounds for EPHA8

Sorafenib

300+

studies

Dasatinib

299+

studies

Crizotinib

298+

studies

All 23 Compounds — Ranked by Evidence

Gefitinib

5.67

confidence

Erlotinib

5.55

confidence

Imatinib

5.47

confidence

Foretinib

4.34

confidence

Tozasertib

4.33

confidence

Vandetanib

4.30

confidence

Nilotinib

4.17

confidence

Bosutinib

4.08

confidence

Doramapimod

4.06

confidence

Canertinib

3.53

confidence

Pelitinib

3.50

confidence

Fedratinib

3.40

confidence

Neflamapimod

3.30

confidence

Dasatinib Anhydrous

3.09

confidence

R 406

2.83

confidence

Cediranib

2.83

confidence

Masitinib

2.77

confidence

Pha 665752

2.71

confidence

Ast 487

2.56

confidence

Raf 265

2.48

confidence

Sorafenib

300+

studies

1.95

confidence

Crizotinib

298+

studies

0.69

confidence

Dasatinib

299+

studies

0.69

confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for EPHA8 (EPH receptor A8). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: EPHA8 target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.